HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemia Biomark Res
The Discovery, Characterization, and Quantification of Bioactive Peptides Contained in Palbio Porcine Intestinal Mucosa Hydrolysate Products Int J Mol Sci
Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia Blood Neoplasia
Patient-derived liver organoids recapitulate liver epithelial heterogeneity and enable precision modeling of alcohol-related liver disease J Hepatol
Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkers Blood Adv
Proteins of the cancer cell secretome induce the protumoral microenvironment of diffuse intrinsic pontine glioma NEURO-ONCOL ADV
Plain language summary on subcutaneous administration of isatuximab in people with relapsed and/or refractory multiple myeloma Future Oncol
Long-term results from the AGILE study of azacitidine plus ivosidenib vs placebo in newly diagnosed IDH1-mutated AML Blood Adv
Belantamab mafodotin plus bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-7): updated overall survival analysis from a global, randomised, open-label, phase 3 trial Lancet Oncol